Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ursula Egner

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Expert Opinion on Drug Discovery|March 16, 2013
A structural biology view of target drugabilityUrsula Egner, Roman C Hillig
Journal of Cutaneous Pathology|July 2, 2003
Adhesion molecules CD171 (L1CAM) and CD24 are expressed by primary neuroendocrine carcinomas of the skin (Merkel cell carcinomas)Martin Deichmann, Hjalmar Kurzen, Ursula Egner, et al.
Journal of Cutaneous Pathology|July 13, 2005
The chemoresistance gene ABCG2 (MXR/BCRP1/ABCP1) is not expressed in melanomas but in single neuroendocrine carcinomas of the skinMartin Deichmann, Marianne Thome, Ursula Egner, et al.
Chembiochem : a European Journal of Chemical Biology|March 3, 2005
The target discovery processUrsula Egner, Jörn Krätzschmar, Bertolt Kreft, et al.
Developmental Biology|December 2, 2006
Compartmentalization of a unique ADP/ATP carrier protein SFEC (Sperm Flagellar Energy Carrier, AAC4) with glycolytic enzymes in the fibrous sheath of the human sperm flagellar principal pieceYoung-Hwan Kim, Gerhard Haidl, Martina Schaefer, et al.
Acta Crystallographica. Section D, Structural Biology|August 29, 2024
Surface-mutagenesis strategies to enable structural biology crystallization platformsMartina Schaefer, Vera Pütter, André Hilpmann, et al.
Journal of Molecular Biology|April 24, 2007
Structural basis for a high affinity inhibitor bound to protein kinase MK2Roman C Hillig, Uwe Eberspaecher, Felipe Monteclaro, et al.
Nature Reviews. Drug Discovery|August 13, 2016
Biophysics in drug discovery: impact, challenges and opportunitiesJean-Paul Renaud, Chun-Wa Chung, U Helena Danielson, et al.
Journal of Medicinal Chemistry|March 22, 2002
Structural basis for the glucocorticoid response in a mutant human androgen receptor (AR(ccr)) derived from an androgen-independent prostate cancerPedro M Matias, Maria Arménia Carrondo, Ricardo Coelho, et al.
Protein Science : a Publication of the Protein Society|November 30, 2006
Identifying protein construct variants with increased crystallization propensity--a case studyGuido A Malawski, Roman C Hillig, Felipe Monteclaro, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Expert Opinion on Drug Discovery|March 16, 2013
A structural biology view of target drugabilityUrsula Egner, Roman C Hillig
Journal of Cutaneous Pathology|July 2, 2003
Adhesion molecules CD171 (L1CAM) and CD24 are expressed by primary neuroendocrine carcinomas of the skin (Merkel cell carcinomas)Martin Deichmann, Hjalmar Kurzen, Ursula Egner, et al.
Journal of Cutaneous Pathology|July 13, 2005
The chemoresistance gene ABCG2 (MXR/BCRP1/ABCP1) is not expressed in melanomas but in single neuroendocrine carcinomas of the skinMartin Deichmann, Marianne Thome, Ursula Egner, et al.
Chembiochem : a European Journal of Chemical Biology|March 3, 2005
The target discovery processUrsula Egner, Jörn Krätzschmar, Bertolt Kreft, et al.
Developmental Biology|December 2, 2006
Compartmentalization of a unique ADP/ATP carrier protein SFEC (Sperm Flagellar Energy Carrier, AAC4) with glycolytic enzymes in the fibrous sheath of the human sperm flagellar principal pieceYoung-Hwan Kim, Gerhard Haidl, Martina Schaefer, et al.
Acta Crystallographica. Section D, Structural Biology|August 29, 2024
Surface-mutagenesis strategies to enable structural biology crystallization platformsMartina Schaefer, Vera Pütter, André Hilpmann, et al.
Journal of Molecular Biology|April 24, 2007
Structural basis for a high affinity inhibitor bound to protein kinase MK2Roman C Hillig, Uwe Eberspaecher, Felipe Monteclaro, et al.
Nature Reviews. Drug Discovery|August 13, 2016
Biophysics in drug discovery: impact, challenges and opportunitiesJean-Paul Renaud, Chun-Wa Chung, U Helena Danielson, et al.
Journal of Medicinal Chemistry|March 22, 2002
Structural basis for the glucocorticoid response in a mutant human androgen receptor (AR(ccr)) derived from an androgen-independent prostate cancerPedro M Matias, Maria Arménia Carrondo, Ricardo Coelho, et al.
Protein Science : a Publication of the Protein Society|November 30, 2006
Identifying protein construct variants with increased crystallization propensity--a case studyGuido A Malawski, Roman C Hillig, Felipe Monteclaro, et al.
Pageof 2